Open AccessGlucuronidase beta is an early predictive marker for the use of antidepressant in the treatment of glioma patients
Author(s) -
Dayuan Xu,
Gang Chen
Publication year - 2022
Publication title -
tropical journal of pharmaceutical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.209
H-Index - 36
eISSN - 1596-5996
pISSN - 1596-9827
DOI - 10.4314/tjpr.v21i10.30
Subject(s) - antidepressant , pharmacology , glioma , drug metabolism , biomarker , medicine , drug , cancer research , biology , oncology , biochemistry , hippocampus